612
Views
0
CrossRef citations to date
0
Altmetric
Licensed Vaccines

The impact of varicella vaccination: A 2005–2019 interrupted time series analysis

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Article: 2278927 | Received 21 Jul 2023, Accepted 31 Oct 2023, Published online: 21 Nov 2023

References

  • Seward JF, Zhang JX, Maupin TJ, Mascola L, Jumaan AO. Contagiousness of varicella in vaccinated cases. JAMA. 2004;292(6):704. doi:10.1001/jama.292.6.704.
  • Ayoade F, Kumar S. Varicella-zoster virus (Chickenpox). 2023.
  • Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–8. doi:10.1080/21645515.2018.1546525.
  • World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265–87. [accessed 2023 Sep 23]. https://pubmed.ncbi.nlm.nih.gov/24983077/.
  • Gabutti G, Franchi M, Maniscalco L, Stefanati A. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs. Minerva Pediatr. 2016;68:213–25.
  • Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122(3):e744–e51. doi:10.1542/peds.2008-0567.
  • Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J. 2010;29(3):199–204. doi:10.1097/INF.0b013e3181bbf2a0.
  • Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program — United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016;65(34):902–5. doi:10.15585/mmwr.mm6534a4.
  • Leung J, Harpaz R. Impact of the maturing varicella vaccination Program on varicella and related outcomes in the United States: 1994–2012. J Pediatric Infect Dis Soc. 2016;5(4):395–402. doi:10.1093/jpids/piv044.
  • World Health Organization. Vaccine introduction in Panama. [accessed 2023 Sep 23]. https://immunizationdata.who.int/pages/vaccine-intro-by-country/pan.html?YEAR=.
  • Boletín Estadístico 2018. Ministerio de Salud de Panamá. Published 2018. [accessed 2023 June 6]. https://www.minsa.gob.pa/sites/default/files/programas/boletin_2018.pdf.
  • Linden A. Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J. 2015;15(2):480–500. doi:10.1177/1536867X1501500208.
  • Hirose M, Gilio AE, Ferronato AE, Ragazzi SLB. Impacto da vacina varicela nas taxas de internações relacionadas à varicela: revisão de dados mundiais. Revista Paulista de Pediatria. 2016;34(3):359–66. doi:10.1016/j.rpped.2015.12.006.
  • Avila-Aguero ML, Ulloa-Gutierrez R, Camacho-Badilla K, Soriano-Fallas A, Arroba-Tijerino R, Morice-Trejos A. Varicella prevention in Costa Rica: impact of a one-dose schedule universal vaccination. Expert Rev Vaccines. 2017;16(3):229–34. doi:10.1080/14760584.2017.1247700.
  • Giachetto G. Varicela: Situación Epidemiológica y Actualización de Las Medidas de Prevención. 2013 [accessed 2023 June 6]. http://www.scielo.edu.uy/scielo.php?script=sci_arttext&pid=S1688-12492013000400011.
  • Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the advisory committee on immunization practices (ACIP). Centers for disease control and prevention. MMWR Recomm Rep. 1996;45(RR–11):1–36.
  • Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine. 2013;31(42):4744–8. doi:10.1016/j.vaccine.2013.08.022.
  • de Martino Mota A, Carvalho-Costa FA. Varicella zoster virus related deaths and hospitalizations before the introduction of universal vaccination with the tetraviral vaccine. J Pediatr (Rio J). 2016;92(4):361–6. doi:10.1016/j.jped.2015.10.003.
  • Jung J, Ko YJ, Kim YE, Huh K, Park BJ, Yoon SJ. Epidemiological impact of the Korean national immunization program on varicella incidence. J Korean Med Sci. 2019;34(7). doi:10.3346/jkms.2019.34.e53.
  • Quinn HE, Gidding HF, Marshall HS, Booy R, Elliott EJ, Richmond P, Crawford N, McIntyre PB, Macartney KK. Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program. J Infect. 2019;78(3):220–5. doi:10.1016/j.jinf.2018.11.009.
  • Barrenechea GGCREPM& SBL. Análisis por series temporales de la incidencia de varicela y el impacto de la implementación de la vacuna en Tucumán. Rev Argent Salud Publica. 2020;12(7):1–7.
  • Sáez-Llorens X, Suman OD, Morós DD, Pilar Rubio MD. Complicaciones y costos asociados a la varicela en niños inmunocompetentes. Revista Panamericana de Salud Pública. 2002;12(2). doi:10.1590/S1020-49892002000800006.
  • Latasa P, Gil de Miguel A, Barranco Ordoñez MD, Rodero Garduño I, Sanz Moreno JC, Ordobás Gavín M, Esteban Vasallo M, Garrido-Estepa M, García-Comas L. Effectiveness and impact of a single-dose vaccine against chickenpox in the community of Madrid between 2001 and 2015. Hum Vaccin Immunother. 2018;14(9):2274–80. doi:10.1080/21645515.2018.1475813.